The Phoenix area's long-standing ozone pollution issues could have serious impacts on local economic competitiveness and ...

A new study has found that lung cancer tumors 'feed' off sugar and shed light on the link between diet and the disease.

Iron Lung channeled this chest-pounding sensation into an aural assault that caught the ears of San Francisco label ...

The drug is being developed for the treatment of small cell lung cancer and neuroendocrine carcinoma, including neuroendocrine prostate cancer. The multi-center, first-in-human, open-label, phase 2/3 ...

The firm is preparing for a trial to show the efficacy of its CyPath Lung test and support a submission to the US Food and Drug Administration for marketing clearance.

Insmed projects 2025 Arikayce revenue of $405M-$425M, while RBC values Arikayce at up to $25 per share with potential label expansion. Join Nic Chahine live on Wednesday, March 19, at 6 PM ET for ...

However, a doctor may still prescribe if you have ROS1-positive lung cancer. This is known as off-label drug use. Off-label drug use means a drug that’s approved by the Food and Drug ...

The approval for the first-line treatment of esophageal squamous cell carcinoma comes shortly after a label expansion for the ...

“We are committed to addressing the remaining unmet need in lung cancer through our broad development programme.” AZ is running several other studies in the hope of extending the labelling for ...

Advocate General (EU AG) recommended that the European Court of Justice (ECJ) overturn the 2022 decision of the General Court annulling the 2019 harmonized classification and labeling of titanium ...